North Capital, Inc. Prothena Corp Public LTD CO Transaction History
North Capital, Inc.
- $106 Billion
- Q1 2025
A detailed history of North Capital, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, North Capital, Inc. holds 159 shares of PRTA stock, worth $1,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
159Holding current value
$1,540% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRTA
# of Institutions
199Shares Held
39.4MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$112 Million7.5% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$37.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$35.7 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$21.7 Million0.44% of portfolio
-
State Street Corp Boston, MA1.86MShares$18 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $455M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...